Bial (Portugal)

Recent papers from Bial (Portugal)

1. Real-World Use of Opicapone in Management of Patients with Parkinson’s Disease and Early Motor Fluctuations in Spain: 12-Month Interim Analysis of REONPARK StudyBrain Sciences · 2026
2. Sublingual apomorphine for Parkinsonian tremor: a post-hoc analysis of pivotal trial dataJournal of Neural Transmission · 2026
3. Comparative Efficacy of Opicapone and Entacapone in the Management of Motor Fluctuations in Parkinson’s Disease (P3-17.002)Neurology · 2026
4. Low Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON Study: Effect of Levodopa Dose (P3-17.010)Neurology · 2026
5. Challenges of Pain in Parkinson's Disease: Results from the OCEAN StudyMovement Disorders · 2026
6. Evolution of inhaled respiratory medications in Portugal from 2004 to 2024Pulmonology · 2026
7. Targeting diaschisis to alleviate memory deficits after experimental strokeNeurobiology of Disease · 2026
8. Long-term follow up of opicapone as add-on to levodopa in Parkinson's patients without motor fluctuationsJournal of Parkinson s Disease · 2026
9. A Randomized, Double‐Blinded, Placebo‐Controlled QTc Study to Evaluate BIA 28–6156 Effect on Cardiac Repolarization in Healthy VolunteersClinical Pharmacology in Drug Development · 2026
10. “Keep track of your own story:” decentralized biobanking for community engagement in biospecimen researchJournal of Information Technology Case and Application Research · 2026
11. Opicapone in Parkinson’s patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON studyClinical Parkinsonism & Related Disorders · 2026
12. Early start of opicapone in Parkinson’s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuationsFrontiers in Neurology · 2025
13. Non-motor symptoms as critical predictors of quality of life in Parkinson’s disease: a machine learning approachHealth and Quality of Life Outcomes · 2025
14. A systematic approach to classify and reduce recurrent deviations in the pharmaceutical industry: A detailed case studyQuality Management Journal · 2025
15. Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson’s disease and OFF episodes: post hoc analyses of a phase III, open-label studyTherapeutic Advances in Neurological Disorders · 2025
16. Comparative Efficacy and Safety of Benzodiazepines in the Treatment of Patients with Generalized Anxiety Disorder: A Systematic Review and Network Meta-AnalysisPsychotherapy and Psychosomatics · 2025
17. A Randomized, Double-Blind, Placebo-Controlled Study on Probiotic Treatment for Halitosis: Novel Insights into Glucose and Phosphorus MetabolismProbiotics and Antimicrobial Proteins · 2025
18. Trends in antidiabetic drug use in Portugal: 8 years real‐world data from a nationwide retrospective observational study (2017–2024) ( TREND ‐8 study)Diabetes Obesity and Metabolism · 2025
19. Pseudomonas brassicacearum-Induced Biotite Weathering: Role of Iron Homeostasis and Two SiderophoresEnvironmental Science & Technology · 2025
20. Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trialJournal of Parkinson s Disease · 2025